secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOXYTRAN, INC (BIXT)
CIK:        0001445815
Form:       8-K
Filed at:   2024-08-20T23:59:59+00:00
Accession:  0001493152-24-033314
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioxytran issues 28.97M preferred shares to insiders, converts 94M common shares and $354K debt
--------------------------------------------------------------------------------

- Issued 28,971,248 convertible preferred shares to insiders in exchange for 94,057,658 common shares at a 5:1 ratio.
- Preferred shares have super voting rights: vote on 'as if converted' basis multiplied by 2; insiders now control 77.9% voting power.
- Conversion also extinguished $353,840 in accrued salaries, accounts receivable, and short-term debt plus 14.41M subsidiary shares.
- Common shares outstanding reduced to 81,850,495; par value $0.001 per share; listed on OTCQB.
- Press release announces peer-reviewed British Journal article on carbon monoxide in mitochondria, using MDX Viewer to validate BXT-25.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445815/000149315224033314/0001493152-24-033314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445815/000149315224033314/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer